| 1 | system | 35,475 |
| 2 | system-mediated | 6 |
| 3 | system-negative | 5 |
| 4 | system™ | 5 |
| 5 | system-blocking | 4 |
| 6 | system-the | 4 |
| 7 | analysator | 2 |
| 8 | check-point | 2 |
| 9 | examination-usa | 2 |
| 10 | ii-aldosterone | 2 |
| 11 | n-arachidonoylethanolamine | 2 |
| 12 | system-dependent | 2 |
| 13 | system-group | 2 |
| 14 | system-inhibition | 2 |
| 15 | system-modulating | 2 |
| 16 | system-positive | 2 |
| 17 | ''3 | 1 |
| 18 | ''4 | 1 |
| 19 | buildling | 1 |
| 20 | canada/congenital | 1 |
| 21 | capacity/ability | 1 |
| 22 | chemo-related | 1 |
| 23 | deviation-associated | 1 |
| 24 | duralith | 1 |
| 25 | endovanilloid | 1 |
| 26 | examination® | 1 |
| 27 | functions.probiotics | 1 |
| 28 | gene-enriched | 1 |
| 29 | hetero-nanocomposites | 1 |
| 30 | impairment-related | 1 |
| 31 | network® | 1 |
| 32 | rate/sensitivity | 1 |
| 33 | sigma-ellipse | 1 |
| 34 | system-1 | 1 |
| 35 | system-activating | 1 |
| 36 | system-active | 1 |
| 37 | system-an | 1 |
| 38 | system-depressant | 1 |
| 39 | system-endocrine | 1 |
| 40 | system-expanded | 1 |
| 41 | system-independent | 1 |
| 42 | system-inhibiting | 1 |
| 43 | system-inhibitor | 1 |
| 44 | system-modifying | 1 |
| 45 | system-selective | 1 |
| 46 | system-stimulating | 1 |
| 47 | system/autophagy | 1 |
| 48 | system/brain-permeable | 1 |
| 49 | system/electrogoniometer | 1 |
| 50 | systems-chads2 | 1 |
| 51 | systems-house | 1 |
| 52 | technique.study | 1 |
| 53 | tovextrinsic | 1 |
| 1 | ''3 | 1 |
| 2 | ''4 | 1 |
| 3 | analysator | 2 |
| 4 | buildling | 1 |
| 5 | canada/congenital | 1 |
| 6 | capacity/ability | 1 |
| 7 | check-point | 2 |
| 8 | chemo-related | 1 |
| 9 | deviation-associated | 1 |
| 10 | duralith | 1 |
| 11 | endovanilloid | 1 |
| 12 | examination-usa | 2 |
| 13 | examination® | 1 |
| 14 | functions.probiotics | 1 |
| 15 | gene-enriched | 1 |
| 16 | hetero-nanocomposites | 1 |
| 17 | ii-aldosterone | 2 |
| 18 | impairment-related | 1 |
| 19 | n-arachidonoylethanolamine | 2 |
| 20 | network® | 1 |
| 21 | rate/sensitivity | 1 |
| 22 | sigma-ellipse | 1 |
| 23 | system | 35,475 |
| 24 | system-1 | 1 |
| 25 | system-activating | 1 |
| 26 | system-active | 1 |
| 27 | system-an | 1 |
| 28 | system-blocking | 4 |
| 29 | system-dependent | 2 |
| 30 | system-depressant | 1 |
| 31 | system-endocrine | 1 |
| 32 | system-expanded | 1 |
| 33 | system-group | 2 |
| 34 | system-independent | 1 |
| 35 | system-inhibiting | 1 |
| 36 | system-inhibition | 2 |
| 37 | system-inhibitor | 1 |
| 38 | system-mediated | 6 |
| 39 | system-modifying | 1 |
| 40 | system-modulating | 2 |
| 41 | system-negative | 5 |
| 42 | system-positive | 2 |
| 43 | system-selective | 1 |
| 44 | system-stimulating | 1 |
| 45 | system-the | 4 |
| 46 | system/autophagy | 1 |
| 47 | system/brain-permeable | 1 |
| 48 | system/electrogoniometer | 1 |
| 49 | systems-chads2 | 1 |
| 50 | systems-house | 1 |
| 51 | system™ | 5 |
| 52 | technique.study | 1 |
| 53 | tovextrinsic | 1 |
| 1 | system-1 | 1 |
| 2 | systems-chads2 | 1 |
| 3 | ''3 | 1 |
| 4 | ''4 | 1 |
| 5 | examination-usa | 2 |
| 6 | tovextrinsic | 1 |
| 7 | system-expanded | 1 |
| 8 | gene-enriched | 1 |
| 9 | deviation-associated | 1 |
| 10 | system-mediated | 6 |
| 11 | chemo-related | 1 |
| 12 | impairment-related | 1 |
| 13 | endovanilloid | 1 |
| 14 | system-the | 4 |
| 15 | system/brain-permeable | 1 |
| 16 | n-arachidonoylethanolamine | 2 |
| 17 | system-endocrine | 1 |
| 18 | ii-aldosterone | 2 |
| 19 | sigma-ellipse | 1 |
| 20 | systems-house | 1 |
| 21 | system-negative | 5 |
| 22 | system-active | 1 |
| 23 | system-selective | 1 |
| 24 | system-positive | 2 |
| 25 | system-blocking | 4 |
| 26 | buildling | 1 |
| 27 | system-modulating | 2 |
| 28 | system-stimulating | 1 |
| 29 | system-activating | 1 |
| 30 | system-inhibiting | 1 |
| 31 | system-modifying | 1 |
| 32 | duralith | 1 |
| 33 | canada/congenital | 1 |
| 34 | system | 35,475 |
| 35 | system-an | 1 |
| 36 | system-inhibition | 2 |
| 37 | system-group | 2 |
| 38 | system/electrogoniometer | 1 |
| 39 | analysator | 2 |
| 40 | system-inhibitor | 1 |
| 41 | functions.probiotics | 1 |
| 42 | hetero-nanocomposites | 1 |
| 43 | system-depressant | 1 |
| 44 | system-dependent | 2 |
| 45 | system-independent | 1 |
| 46 | check-point | 2 |
| 47 | technique.study | 1 |
| 48 | system/autophagy | 1 |
| 49 | capacity/ability | 1 |
| 50 | rate/sensitivity | 1 |
| 51 | system™ | 5 |
| 52 | network® | 1 |
| 53 | examination® | 1 |